| | COMPOUND: C07661 | |
Entry |
|
Name |
|
Formula |
C19H22FN3O4
|
Exact mass |
375.1594
|
Mol weight |
375.3941
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MA Fluoroquinolones
J01MA16 Gatifloxacin
D08011 Gatifloxacin (INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AE Fluoroquinolones
S01AE06 Gatifloxacin
D08011 Gatifloxacin (INN)
USP drug classification [BR:br08302]
Ophthalmic Agents
Ophthalmic Anti-Infectives
Antibacterials, Ophthalmic
Gatifloxacin
D08011 Gatifloxacin (INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG01549 Fluoroquinolone
DG00628 Gatifloxacin
D08011 Gatifloxacin
Drug classes [BR:br08332]
Antibacterial
DG01549 Fluoroquinolone
D08011 Gatifloxacin
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Fluoroquinolone
D08011 Gatifloxacin (INN)
|
Other DBs |
|
KCF data |
ATOM 27
1 C8y C 29.4634 -15.0276
2 N4y N 30.6821 -15.7214
3 C8y C 29.4517 -13.6338
4 C8y C 28.2561 -15.7390
5 C1y C 30.6704 -17.1270
6 C8x C 31.8835 -15.0042
7 C8y C 30.6529 -12.9281
8 C8x C 28.2385 -12.9340
9 C8y C 27.0431 -15.0509
10 O2a O 28.3085 -17.1504
11 C1x C 31.3702 -18.3459
12 C1x C 29.9590 -18.3343
13 C8y C 31.8718 -13.6105
14 O5x O 30.6413 -11.5227
15 C8y C 27.0373 -13.6396
16 N1y N 25.9116 -15.8264
17 C1a C 27.3172 -18.1476
18 C6a C 33.0791 -12.9107
19 X F 25.8184 -12.9457
20 C1x C 25.9116 -17.2259
21 C1x C 24.6986 -15.1324
22 O6a O 34.2919 -13.6162
23 O6a O 33.1431 -11.5110
24 C1y C 24.7044 -17.9316
25 C1x C 23.4855 -15.8264
26 N1x N 23.4855 -17.2259
27 C1a C 24.6869 -19.3313
BOND 30
1 9 15 2
2 11 12 1
3 25 26 1
4 1 2 1
5 1 3 1
6 1 4 2
7 2 5 1
8 2 6 1
9 3 7 1
10 3 8 2
11 4 9 1
12 4 10 1
13 5 11 1
14 5 12 1
15 6 13 2
16 7 14 2
17 8 15 1
18 9 16 1
19 10 17 1
20 13 18 1
21 15 19 1
22 16 20 1
23 16 21 1
24 18 22 1
25 18 23 2
26 20 24 1
27 21 25 1
28 24 26 1
29 24 27 1
30 7 13 1
|
|
» Japanese version
|
|